A
B
C
D
E
F
G
H
I
K
L
M
N
O
P
Q
R
S
T
U
V
W

Kappa Bioscience AS

Company-logo  COMPANY DETAILS
Kappa Bioscience AS
Silurveien 2, Building B
Oslo
0380
Norway
Website
Mail
Call

+49 40 6094087 0




HEALTH CATEGORIES

aging; cardiovascular health; children's nutrition; mobility; women’s health



Kappa Bioscience is producer of premium K2VITAL® vitamin K2 MK-7 and microencapsulated K2VITAL® DELTA for stability in mineral formulations. Vitamin K2 supports Bone health by activating the proteins that incorporate calcium into bone, and prevent excess calcium from deposit in vessels and arteries. K2 compliments top-selling D3, Ca, Mg and Omega-3 in a wide variety of dose formats. Kappa is the publisher of the K2 Formulation LookBook – a complete primer on K2 plus 120+ ready-to-launch formulations.

Kappa Bioscience has the vision to deliver vitamin K2 to the mass market, making it accessible for everybody, everywhere. Positioned for unlimited-scale market opportunities, Kappa Bioscience offers you a strong partner in the development of new market growth with K2VITAL®.



Articles On Nutrition Insight
FormattedPicture

NUTRITION & HEALTH NEWS

Research unveils vitamin D deficiency may cause inflammation resulting in chronic illness

08 Aug 2022 --- Increasing vitamin D levels in deficient patients could lower chronic inflammation as there is a direct link between low levels of vitamin D and high levels of inflammation,... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

A reduced form of vitamin K can prevent cellular degradation, experts flag

04 Aug 2022 --- Researchers have discovered that vitamin K hydroquinone, a reduced form of vitamin K, can prevent a type of natural cell death called ferroptosis. The findings may open new pathways... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

Karallief lands US patent for “fast-acting” joint relief blend, eyeing formulation partnerships

29 Jun 2022 --- Nutraceutical company, Karallief has been granted a US patent for Easy Climb, a new “fast-acting” herbal extract formula shown to relieve occasional joint discomfort by... Read More

FormattedPicture

BUSINESS NEWS

Weekly Roundup: Balchem completes Kappa Bioscience US$338M acquisition, Lallemand unveils probiotic production hub

24 Jun 2022 --- This week in nutrition news, Balchem completed its acquisition of Kappa Bioscience for a value of NOK 3.175 billion (US$338 million). Lallemand Health Solutions inaugurated a new... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

Balchem acquires vitamin K2 specialist Kappa Bioscience eyeing EU market

15 Jun 2022 --- US-based Balchem is acquiring Norwegian Kappa Bioscience from Verdane Edda for 3.175B NOK (US$338 million – at the time of the acquisition). A definite agreement has been... Read More




Videos
FormattedPicture

“The forgotten vitamin”: K2’s bioactive difference from K1

09 Nov 2021 --- Recent science is propelling vitamin K2 into the spotlight as a crucial micronutrient that is missing from the Western diet. Dominik Mattern, vice president marketing at Kappa Bioscience, details its role in combination with D3 in the calcium metabolism. He also explains that widespread confusion with K1 has limited K2’s reach, despite its “very different” bioactivity.

FormattedPicture

How to tap into growing understanding of vitamin K2

05 Jun 2019 --- The growing body of scientific evidence and consumer understanding supporting the benefits of vitamin K2 is providing suppliers with increased options for NPD. At Vitafoods Europe 2019, NutritionInsight spoke with Egil Greve, CEO at Kappa Bioscience AS, about innovative prototypes and product formats.

FormattedPicture

Growing the market for vitamin K2

05 Mar 2019 --- At Nutraceuticals Europe in Madrid, Spain, Maren Janecke, Senior Sales Manager at Kappa Bioscience, explains the growing market potential and consumer interest for vitamin K2. 




Podcasts
FormattedPicture

NewsBite Podcast (Jul 19-23): “Pandemic stress causes ‘alarming’ use of supplements, reveals survey”

26 Jul 2021 --- This week’s NewsBite podcast details how COVID-19 has had a major impact on consumer habits around supplementation, with NPD tackling everything from weight management to immunity. Additionally, Kappa Bioscience investigated the link between COVID-19 outcomes and levels of vitamins D and K2.

FormattedPicture

NewsBite Podcast (Jun 14-18): “Vitamin consumers turn to Seneque’s NMN supplements to boost cellular health”

21 Jun 2021 --- The last week saw developments in boosting cellular health with NMN supplements and untangling the connection between COVID-19 mortality and vitamin K2. In the D2C space, Probi is set to provide Swedish cosmetics company Oriflame its first gut health probiotic, while Unilever acquired Paula’s Choice skincare.

FormattedPicture

NewsBite Podcast (Feb 8-12): “Cargill leads US$55M funding round for Evolve BioSystems’ infant nutrition probiotic”

15 Feb 2021 --- During the last week, Evolve BioSystems landed US$55 million for the commercialization of its “next generation of probiotic.” Other top stories include Lonza’s US$4.7 billion sale of its Speciality Ingredients business and Kappa Bioscience’s US expansion of its vitamin K2 production.

FormattedPicture

NewsBite Podcast (November 16-20): “Persona Nutrition expands personalized supplements, Innova Market Insights details Tailored to Fit trend”

23 Nov 2020 --- This week’s NutritionInsight NewsBite podcast details the personalization trend, which is ushering in a new norm for bespoke foods, beverages and supplements, according to Innova Market Insights. Tapping into that same trend, Persona Nutrition expanded its supplements portfolio to address sleep, energy, stress and immunity in novel capsule designs. Read MorePersona expands line of personalized supplements to boost sleep, energy, stress and immunityTailored to fit: Innova Market Insights spotlights “ever-expanding” personalized nutritionKappa Bioscience supports research on vitamin K deficiency and COVID-19 severity link




A
B
C
D
E
F
G
H
I
K
L
M
N
O
P
Q
R
S
T
U
V
W